Drug class
Ophthalmic Beta-Blockers
Ophthalmic beta-blockers are a class of topical ocular medications, available in both nonselective and beta-1 selective formulations, designed to manage elevated intraocular pressure. Read more about Ophthalmic Beta-Blockers
70 drugs in this class 34 manufacturers
Drugs in Ophthalmic Beta-Blockers
TIMOLOL MALEATE (timolol maleate/PF)
DORZOLAMIDE-TIMOLOL (dorzolamide HCl/timolol maleate)
TIMOLOL MALEATE
TIMOLOL MALEATE
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
BRIMONIDINE TARTRATE-TIMOLOL (brimonidine tartrate/timolol maleate)
DORZOLAMIDE-TIMOLOL (dorzolamide HCl/timolol maleate)
TIMOLOL MALEATE
Ophthalmic beta-blockers are a class of topical ocular medications, available in both nonselective and beta-1 selective formulations, designed to manage elevated intraocular pressure.
They function primarily by antagonizing beta-adrenergic receptors located in the ciliary body epithelium, which significantly reduces the production of aqueous humor.
Clinically, these agents serve as a primary therapeutic option to lower intraocular pressure and prevent glaucomatous optic nerve damage, most notably in open-angle glaucoma and ocular hypertension.
Common agents in this class include timolol, betaxolol, and levobunolol.
-
fda.gov
Ophthalmic beta-blockers are a class of topical ocular medications, available in both nonselective and beta-1 selective formulations, designed to manage elevated intraocular pressure Clinically, these agents serve as a primary therapeutic option to lower intraocular pressure and prevent glaucomatous optic nerve damage, most notably in open-angle glaucoma and ocular hypertension
-
nih.gov
Ophthalmic beta-blockers are a class of topical ocular medications, available in both nonselective and beta-1 selective formulations, designed to manage elevated intraocular pressure They function primarily by antagonizing beta-adrenergic receptors located in the ciliary body epithelium, which significantly reduces the production of aqueous humor Common agents in this class include timolol, betaxolol, and levobunolol
-
nih.gov
They function primarily by antagonizing beta-adrenergic receptors located in the ciliary body epithelium, which significantly reduces the production of aqueous humor
-
fda.gov
Clinically, these agents serve as a primary therapeutic option to lower intraocular pressure and prevent glaucomatous optic nerve damage, most notably in open-angle glaucoma and ocular hypertension
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.